These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19513106)

  • 21. Toward an information-motivation-behavioral skills model of microbicide adherence in clinical trials.
    Ferrer RA; Morrow KM; Fisher WA; Fisher JD
    AIDS Care; 2010 Aug; 22(8):997-1005. PubMed ID: 20552466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbicide clinical trial adherence: insights for introduction.
    Woodsong C; MacQueen K; Amico KR; Friedland B; Gafos M; Mansoor L; Tolley E; McCormack S
    J Int AIDS Soc; 2013 Apr; 16(1):18505. PubMed ID: 23561044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The last decade of microbicide clinical trials in Africa: from hypothesis to facts.
    Ramjee G; Kamali A; McCormack S
    AIDS; 2010 Oct; 24 Suppl 4():S40-9. PubMed ID: 21042052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical and methodological issues in microbicide trial design.
    Crook AM; Nunn AJ
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):463-71. PubMed ID: 22305929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Provision of investigational drug after clinical research: review of literature, national and international guidelines.
    Dainesi SM; Goldbaum M
    Rev Assoc Med Bras (1992); 2011; 57(6):710-6. PubMed ID: 22249554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interscience Conference on Antimicrobial Agents and Chemotherapy--46th annual meeting. 27-30 September 2006, San Francisco, CA, USA.
    Turner B
    IDrugs; 2006 Nov; 9(11):761-4. PubMed ID: 17096294
    [No Abstract]   [Full Text] [Related]  

  • 29. Trial by science. The basics of clinical research.
    Tsai A
    Diabetes Forecast; 2014 Dec; 67(12):48-52. PubMed ID: 25872366
    [No Abstract]   [Full Text] [Related]  

  • 30. The evolving design and methods for trials evaluating the safety of candidate vaginal microbicides: a systematic review.
    Jespers V; Millwood IY; Poynten IM; Van Damme L; Kaldor JM
    Sex Transm Dis; 2013 Sep; 40(9):729-36. PubMed ID: 23945427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.
    Miller L; Prieto Merino D; Baisley K; Hayes R
    PLoS One; 2022; 17(5):e0267011. PubMed ID: 35551324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. State payer mandates to cover care in US oncology trials: do science and ethics matter?
    Taylor PL
    J Natl Cancer Inst; 2010 Mar; 102(6):376-90. PubMed ID: 20197514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Children's views on taking medicines and participating in clinical trials.
    Nordenmalm S; Kimland E; Ligas F; Lehmann B; Claverol J; Nafria B; Tötterman AM; Pelle B
    Arch Dis Child; 2019 Sep; 104(9):900-905. PubMed ID: 31201156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Content analysis of local newspaper coverage of the microbicide trials in South Africa.
    Cooper S; Anafi P; Sun C; Naidoo N; Reddy P; Buchanan D
    Int Q Community Health Educ; 2008-2009; 29(2):105-21. PubMed ID: 19546087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients in test won't get drug, Amgen decides.
    Pollack A
    N Y Times Web; 2005 Feb; ():C1, C2. PubMed ID: 15742509
    [No Abstract]   [Full Text] [Related]  

  • 37. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies.
    McGowan I; Taylor DJ
    Sex Transm Dis; 2010 Jun; 37(6):361-4. PubMed ID: 20514687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy: an update on new antibiotics, novel non-antibacterial treatment modalities and critical issues in antibiotic resistance.
    Alekshun MN
    Expert Opin Investig Drugs; 2005 Jan; 14(1):93-9. PubMed ID: 15709926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the therapeutic misconception.
    Miller FG; Joffe S
    Kennedy Inst Ethics J; 2006 Dec; 16(4):353-66. PubMed ID: 17847601
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.